Azithromycin and doxycycline should not be used in the management of COVID-19, DHSC advises
Azithromycin and doxycycline should not be used in the management of COVID-19, the Department of Health and Social Care has advised.
Source: The Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research
More News: Azithromycin | COVID-19 | Department of Health | Doxycycline | Drugs & Pharmacology | Zithromax